Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this trial is to investigate the safety profile
of recombinant factor XIII (rFXIII) assessed by the occurrence of adverse events in healthy
Japanese subjects. In addition pharmacokinetic parameters will be investigated.